Financial News
Alnylam Pharmaceuticals (NQ: ALNY )
272.64
-4.69
(-1.69%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Alnylam Pharmaceuticals
![](https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/ALNY.png?width=1200&height=800&fit=crop)
Why Is Alnylam Pharmaceuticals Stock Trading Lower On Thursday?
February 15, 2024
Via Benzinga
Exposures
Product Safety
![](https://g.foolcdn.com/editorial/images/765488/scientist-looking-through-microscope.jpg)
![](https://mms.businesswire.com/media/20240215594931/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Alnylam Pharmaceuticals's Earnings Outlook
February 14, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
(ALNY) - Analyzing Alnylam Pharmaceuticals's Short Interest
February 06, 2024
Via Benzinga
![](https://mms.businesswire.com/media/20240129143350/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://www.investors.com/wp-content/uploads/2020/08/Stock-regeneron-01-shutt.jpg)
![](https://mms.businesswire.com/media/20240109327860/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://mms.businesswire.com/media/20240107331926/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Analyst Expectations for Alnylam Pharmaceuticals's Future
December 08, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Expert Ratings for Alnylam Pharmaceuticals
November 15, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/01/04/screenshot_2024-01-04_at_6.46.30_pm.png?width=1200&height=800&fit=crop)
2024 And Beyond – Exploring Six Investment Megatrends With Tema ETFs
January 04, 2024
Via Benzinga
Topics
ETFs
![](https://cdn.benzinga.com/files/images/story/2023/options_image_4.jpeg?width=1200&height=800&fit=crop)
10 Health Care Stocks Whale Activity In Today's Session
January 02, 2024
Via Benzinga
![](https://mms.businesswire.com/media/20240102586216/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/biotech-shutter.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Alnylam Pharmaceuticals
November 01, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/12/22/azn-ions_0.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20231213336564/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://www.marketbeat.com/logos/articles/med_20231208090552_3-biotech-powerhouses-poised-to-thrive-amid-sector.jpg)
![](https://mms.businesswire.com/media/20231205922348/en/1161817/5/Alnylam_Corporate_Logo.jpg)
Alnylam to Webcast Virtual R&D Day
December 06, 2023
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/12/04/krro.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20231130987077/en/1161817/5/Alnylam_Corporate_Logo.jpg)
Alnylam Ranks #1 on Boston Globe’s Top Places to Work List for 2023
November 30, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20231111731245/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://mms.businesswire.com/media/20231107524076/en/1161817/5/Alnylam_Corporate_Logo.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20231102700234/en/1161817/5/Alnylam_Corporate_Logo.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.